The Belgian Debt Agency informs that it has accepted bids for a total amount of EUR 0.500 billion, distributed into the following lines :OLO 3.00%  22/06/2033 (OLO 97)ISIN Code : BE0000357666 - 22/06/2033Amount taken (EUR billion) : 0.300Weighted average yield : 3.182%Bid-to-cover ratio : 2.28OLO 2.85%  22/10/2034 (OLO 100)ISIN Code : BE0000360694 - 22/10/2034Amount taken (EUR billion) : 0.200Weighted average yield : 3.319%Bid-to-cover ratio : 3.25See our Refinitiv page BELG/ORI or Bloomberg...

The Belgian Debt Agency informs that the following 2 OLO lines will be auctioned on Friday 07 March 2025 for a maximum amount of EUR 500 million :1.Description : OLO 3.00%  22/06/2033ISIN code : BE0000357666OLO number : OLO 97Outstanding : EUR 19 566 000 000.002.Description : OLO 2.85%  22/10/2034ISIN code : BE0000360694OLO number : OLO 100Outstanding : EUR 16 538 000 000.00Payment date will be 11 March 2025.

The annual biovigilance report includes all serious adverse events and reactions occurring during the treatment and use of substances of human origin from 1 January 2023 to 30 June 2024. In 2023, the reproductive system accounted for the majority of notifications.

Press release from the Belgian Debt Agency

Press release of the Belgian Federal Debt Agency

Press release from the Belgian Debt Agency

Press release from the Belgian Debt Agency

In April 2024, the Critical Medicines Alliance was established under the Belgian Presidency of the Council of the European Union. The goal of the Alliance is to foster collaboration among policymakers and stakeholders, and develop a robust and responsive system for the supply of critical medicines in the European Union. Today, on 28 February 2025, the Critical Medicines Alliance presents its strategic report. This report will be used as the basis for new European legislation on medicines...

Press release from the Belgian Debt Agency